Do Tech Giants Violate HIPAA by Tracking Trends?

The Social Dilemma of Health (SDoH).

In March 2018, the world was shocked when it became public knowledge that Cambridge Analytica, a company based in the United Kingdom, had used data from Facebook to impact the presidential election in the United States. It turned out that they had also provided data to the groups supporting Brexit in the U.K.

It should not be a surprise that Facebook had shared data on its users for profit. Facebook said they allowed some access to Cambridge Analytica, but the company had used survey questions to hack into Facebook data, in a manner not intended by Facebook. I am dubious about this claim. The old saying in technology is that if the product is free, then the user is the product. 

The business models of Facebook, Twitter, Instagram, and TikTok are similar in that the service to users is free. Companies that wish to advertise on these platforms get the benefit of placing the user’s eyeballs on screens where advertisements are seen. 

First, advertisers get access to the age, race, sex, and lots of other demographic information on the people that click on the advertisers’ “landing pages” from the social media platform. This is the information companies get when you simply access their site. 

Media companies like Facebook also know what social groups you joined and, critically, with whom you are connected. They create user “profiles” with various amounts of sensitive data. 

In the case of Cambridge Analytica, they obtained 87 million Facebook user profiles. Included with these profiles were Facebook pages each user “liked.” Also included in the profiles were the user’s date of birth and location.     

In the case of Google, in exchange for answering users’ Internet searches, the company has information not just on what was searched for, but in many cases, on every location users have been, sometime for years.

Let’s go back to our first observation about social media companies. Users are the product. While Facebook apologized for the Cambridge Analytica breach, what they didn’t say was that they had stopped collecting and selling this data in some fashion.    

In the case of healthcare, I ask the question: does having data, even if it is saved in grouped data, violate the Health Insurance Portability and Accountability Act (HIPAA)? If the manufacturer of a drug used to treat hemophilia knows the number of people searching for its drug by ZIP code, directly or indirectly, does this violate at least the spirit of HIPAA? 

I understand that Facebook and Google hope you believe that they do not maintain data at an individual level. They say that the data they sell to advertisers excludes individual data. I would argue that by simply reviewing enough of the data they sell, advertisers could match data to individuals. This is how collection companies perform “skip tracing:” finding people to collect unpaid accounts. 

I think it is time to look at how much data technology companies have that may constitute a violation of HIPAA. I also think it is time not to consider just individual data, but how data summarized into grouped data may violate HIPAA.  

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn
Email
Print

Timothy Powell, CPA, CHCP

Timothy Powell is a nationally recognized expert on regulatory matters, including the False Claims Act, Zone Program Integrity Contractor (ZPIC) audits, and U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) compliance. He is a member of the RACmonitor editorial board and a national correspondent for Monitor Mondays.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

The CMS Two-Midnight Rule and short-stay audits are here to stay, impacting inpatient and outpatient admissions, ASC procedures, and Medicare Parts C & D. New for 2024, the Two-Midnight Rule applies to Medicare Advantage patients, requiring differentiation between Medicare plans affecting Case Managers, Utilization Review, and operational processes and knowledge of a vital distinction between these patients that influences post-discharge medical reviews and compliance risk. Join Michael G. Calahan for a comprehensive webcast covering federal laws for all admission processes. Gain the knowledge needed to navigate audits effectively and optimize patient access points, personnel, and compliance strategies. Learn Two-Midnight Rule essentials, Medicare Advantage implications, and compliance best practices. Discover operational insights for short-stay admissions, outpatient observation, and the ever-changing Inpatient-Only Listing.

Print Friendly, PDF & Email
September 19, 2023
Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Explore comprehensive guidelines and best practices for secondary diagnosis coding in our illuminating webcast. Delve into the intricacies of accurately assigning secondary diagnosis codes to ensure precise medical documentation. Learn how to navigate complex scenarios and adhere to coding regulations while enhancing coding proficiency. Our expert-led webcast covers essential insights, including documentation requirements, sequencing strategies, and industry updates. Elevate your coding skills and stay current with the latest coding advancements so you can determine the correct DRG assignment to optimize reimbursement, support medical decision-making, and maintain compliance.

Print Friendly, PDF & Email
September 20, 2023
Principal Diagnosis Coding: Mastering Selection and Sequencing

Principal Diagnosis Coding: Mastering Selection and Sequencing

Enhance your inpatient coding precision and revenue with Principal Diagnosis Coding: Mastering Selection and Sequencing. Join our expert-led webcast to conquer the challenges of principal diagnosis selection and sequencing. We’ll decode the intricacies of ICD-10-CM guidelines, equipping you with a clear grasp of the rules and the official UHDDS principal diagnosis definition. Uncover the crucial role of coding conventions, master the sequencing of related conditions, and confidently tackle cases with equally valid principal diagnoses.

Print Friendly, PDF & Email
September 14, 2023
2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY24 Inpatient Prospective Payment System (IPPS) Final Rule, including new ICD-10-CM/PCS codes, plus insights, analysis and answers to questions from the country’s most respected subject matter experts.

Print Friendly, PDF & Email
2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

This third session in our 2024 IPPS Summit will feature a review of FY24 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from two acclaimed subject matter experts

Print Friendly, PDF & Email
August 17, 2023

Trending News